Latest News & Updates

Breaking News

  • 20 hours ago

  • Simantini Singh Deo

AbbVie Achieves Nine-Year CLL14 Results for Venetoclax in First-Line CLL at EHA 2026
Breaking News
KIHT Gains Government Approval to Conduct Clinical Research for Drugs and Medical Devices in India

Simantini Singh Deo

Other trending news you may like to read

AbbVie Achieves Nine-Year CLL14 Results for Venetoclax in First-Line CLL at EHA 2026

AbbVie's nine-year CLL14 data show 7.6-year median time to next treatment, reshaping venetoclax supply and lifecycle planning.

Simantini Singh Deo

Pharma Now

KIHT Gains Government Approval to Conduct Clinical Research for Drugs and Medical Devices in India

KIHT receives government approval to operate as a CRO for drugs and medical devices, expanding India's clinical research capacity.

Simantini Singh Deo

Pharma Now

Indian Pharmacopoeia Commission Convenes Conclave to Shape IP 2026 Compliance and Quality Standards

IPC's IP 2026 conclave signals tightening compliance timelines for manufacturers in and exporting to India.

Simantini Singh Deo

Pharma Now

India Targets US$130 Billion Pharma Market and US$80 Billion in Exports by 2030, ASSOCHAM Projects

ASSOCHAM projects India's pharma market at US$130B and exports at US$80B by 2030, with biosimilars, biologics, and regulatory harmonization as key drivers.

Simantini Singh Deo

Pharma Now